secwatch.observer — SEC 8-K summary
======================================

Issuer:     Penumbra Inc (PEN)
CIK:        0001321732
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001321732-26-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Penumbra Q4 revenue $385.4M (+22.1%); operating income $59.2M; FY25 rev $1.4B (+17.5%)
--------------------------------------------------------------------------------

- Revenue $385.4M for Q4, up 22.1% YoY (20.9% constant currency). US Thrombectomy $203.1M (+12.4%).
- Gross margin 68.0% vs 66.8% a year ago; operating margin 15.4%.
- Net income $47.3M; adjusted EBITDA $79.1M (20.5% margin).
- Full year revenue $1,403.7M, up 17.5%; net income $177.7M; adjusted EBITDA $266.8M.
- Embolization & access revenue grew 37.0% in Q4; international revenue up 27.7% (21.9% constant currency).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321732/000132173226000006/0001321732-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321732/000132173226000006/pen-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001321732-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer